Getting older is a natural part of life, and as we age, our bodies slowly stop working as well as they used to.
We also become more likely to get sick. Scientists are still trying to understand exactly why this happens and how to slow it down.
While no one has found a way to completely stop aging, there are some ideas that could help
people stay healthier for longer.
One idea is called caloric restriction. This means eating fewer calories each day while still getting all the vitamins and nutrients your body needs. Studies have shown that this can help animals live longer and stay healthier. But eating less all the time is very hard for most people. It can also lead to problems like feeling tired or not getting enough nutrition.
That’s why scientists are now looking for medicines that can give the same benefits as eating less—without actually having to eat less. These are called “caloric restriction mimetics.”
Some of the drugs being studied include metformin (used for diabetes), rapamycin (used after organ transplants), and resveratrol (found in red wine). These drugs have shown some promise in helping animals live longer. But they have problems too—some need to be injected, others don’t absorb well, and some can cause serious side effects.
Now, researchers at the University of Liverpool have found something new. They discovered that a common blood pressure medicine called rilmenidine might help slow down aging. Rilmenidine is already used safely by many people to treat high blood pressure, and it’s taken as a simple pill.
In their study, scientists tested rilmenidine on animals like worms, fruit flies, and mice. They found that both young and older animals lived longer when they took this medicine. The animals also stayed healthier, just like those on a calorie-restricted diet.
The drug works by targeting a specific part of the body called the I1-imidazoline receptor, or nischarin-1. When this receptor is activated, it causes changes in the body that help improve health and increase lifespan.
What’s exciting is that rilmenidine already has a good safety record. It only causes mild side effects, and because it’s already approved for use, it might be easier to study and use as an anti-aging treatment.
As more people around the world get older, even a small delay in aging could make a big difference. It could mean more years of good health, fewer medical problems, and better quality of life.
The idea of using existing drugs for new purposes is also very appealing. Since these drugs have already been tested for safety, they could be approved for new uses much faster and at lower cost.
While we still need more research to know exactly how rilmenidine works in humans, this study is a hopeful step toward finding simple ways to live longer and stay healthier. It shows that we may not need new miracle drugs—we might already have some useful tools in our medicine cabinets.
In the future, rilmenidine could become an important part of helping people stay strong and healthy as they age.
Copyright © 2025 Knowridge Science Report. All rights reserved.
